A forum for researchers, students and applicants in the field of cyclodextrin technology
100% of patients who completed the trial improved or remained stable, and 89% met the efficacy outcome measure of improvement
Cyclolab, the oldest, world renowned cyclodextrin research, development and manufacturing company, and EpiPharma, a bio-pharmaceutical services and peptide drug development
The CDNews blog was created in July and after a short period of trial it started in September. During this
Nitric oxide (NO) is a signaling molecule produced by almost all types of organisms ranging from bacteria to plants and
A paper has just come out in Macromolecular Rapid Communications highlighting the potential benefits of cyclodextrin-based macromolecular systems as cholesterol-mopping
If you are following advances in the re-discovery of cyclodextrins as APIs, there is quite a race among the candidates
Clearly, understanding the mechanism of action for cyclodextrins and consequently finding the most appropriate canditate for the treatment of Niemann
Wittkowski et al. recently published their results on re-evaluation of three genome-wide association studies using computational biostatistics approach. The genetic
Matencio et al. reported in their recent paper that 92.8% of HPBCD administered intrathecally to a child suffering from Niemann
